Stem cell exosomes plus laser shows promise for stubborn melasma
NCT ID NCT06677931
First seen Jan 30, 2026 · Last updated May 05, 2026 · Updated 9 times
Summary
This study tested a new treatment for melasma, a stubborn skin condition causing dark patches on the face. Researchers combined umbilical cord stem cell exosomes with a non-ablative fractional laser in 30 adults aged 18 to 60. The goal was to see if this combination could reduce pigmentation and repair skin damage better than laser alone. Results focused on changes in the Melasma Area and Severity Index (MASI) and physician ratings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Union Hospital of Fujian Medical University
Fuzhou, Fujian, 350001, China
-
Chenxiaosong
Fujian, Fuzhou, 350001, China
Conditions
Explore the condition pages connected to this study.